Metraipolis › archive › dc_a453aa29fece
Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations — Europe PMC PMID:42755980
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42755980
- DOI
- 10.3389/fphar.2026.1868595
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T04:39:56.796Z
- SHA-256 of the archived text
e99285754ec4ffe73cdcc6c0c8ab2cabbdab49b4cbaccd8fd36564053084480f- Stable URL of this page
https://metraipolis.com/documento/dc_a453aa29fece
How to cite
Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations — Europe PMC PMID:42755980 — Europe PMC (en), https://europepmc.org/article/MED/42755980 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a453aa29fece (Metraipolis archive dc_a453aa29fece, sha256 e99285754ec4ffe73cdcc6c0c8ab2cabbdab49b4cbaccd8fd36564053084480f)
BibTeX
@misc{dca453aa29fece,
title = {Targeting pancreatic cancer with natural compounds: molecular mechanisms, preclinical evidence, clinical perspectives, and limitations — Europe PMC PMID:42755980},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42755980},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a453aa29fece; sha256 e99285754ec4ffe73cdcc6c0c8ab2cabbdab49b4cbaccd8fd36564053084480f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755980. Agents can read the archived copy with the MCP tool read_document.